LK
LALIT KUMAR
Also known as: Kumar L
National Institute of Pharmaceutical Education and Research, Delhi Pharmaceutical Sciences and Research University, Manipal University, Himalayan Pharmacy Institute
Employment
-
National Institute of Pharmaceutical Education and Research Assistant Professor2023 - Present
-
Delhi Pharmaceutical Sciences and Research University Assistant Professor2022 - 2023
-
Manipal Academy of Higher Education Lecturer to Assistant Professor - Selection Grade2010 - 2022
-
Sikkim Manipal University Lecturer2010 - 2010
-
Himachal Institute of Pharmacy, Sirmour, Paonta Sahib, HP Lecturer2009 - 2010
Education
-
Manipal University PhD (Pharmaceutical Sciences)2011 - 2016
-
Himalayan Pharmacy Institute M Pharma2007 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (172)
- Controlled Co-release of D-Cycloserine and Moxifloxacin from Mesoporous Nanoparticles for Synergistic MDR-TB Treatment Save
- Development of Diclofenac Acid Encapsulated Transferosomal gel with Enhanced Antioxidant and Anti-Inflammatory Activities for the Management of Musculoskeletal Pain Save
- Development and validation of an eco-friendly RP-HPLC method for the quantification of lurasidone in complexed nano-formulation with forced degradation studies Save
- Forced degradation study and HPLC-UV eco-friendly analytical method for olanzapine quantification in complex nano-formulation matrices Save
- EXPLORING POTENTIAL OF NOVEL HETEROCYCLIC COMPOUNDS AND THEIR STRUCTURE-ACTIVITY RELATIONSHIP IN PROSTATE CANCER TREATMENT Save
- An AQbD-based Optimized and Green Isocratic HPLC Method for the Quantification of Simvastatin in Liposomes: Forced Degradation, Assessment of Drug Content, and Drug Entrapment Save
- Antioxidant and anticancer activities of hesperetin and its novel formulations in KB cells Save
- Applications of nanocarriers in colon targeting Save
- Comparative Evaluation of 5% Pyrophosphate-containing Toothpaste with a Standard Fluoridated Toothpaste in the Inhibition of Calculus Formation: A Single-blind Randomized Controlled Clinical Trial Save
- Conjugate Delivery of D-Cycloserine and Moxifloxacin via Hydrolysable Cross Linkers -Mesoporous Silica Nanoparticles for Synergistic Effect on Multiple Drug Resistant on Tuberculosis Save